Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Reddy's Laboratories Limited
  6. Summary
    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 01/17
4673.6 INR   -0.31%
06:35aDR REDDY LABORATORIES : Hyderabad, India, January 17th, 2022 - Form 6-K
PU
01/14Asian ADRs Move Higher in Friday Trading
MT
01/12Asian ADRs Move Higher in Wednesday Trading
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
01/11/2022 01/12/2022 01/13/2022 01/14/2022 01/17/2022 Date
4671.05 4690.8 4726.15 4688.2 4673.6 Last
5396 11272 5955 5794 7381 Volume
-0.49% +0.42% +0.75% -0.80% -0.31% Change
Estimated financial data (e)
Sales 2022 215 B 2 876 M 2 876 M
Net income 2022 29 510 M 396 M 396 M
Net cash position 2022 17 146 M 230 M 230 M
P/E ratio 2022 26,5x
Yield 2022 0,62%
Sales 2023 241 B 3 237 M 3 237 M
Net income 2023 36 959 M 496 M 496 M
Net cash position 2023 36 785 M 493 M 493 M
P/E ratio 2023 21,2x
Yield 2023 0,68%
Capitalization 775 B 10 440 M 10 398 M
EV / Sales 2022 3,54x
EV / Sales 2023 3,06x
Nbr of Employees 22 739
Free-Float -
More Financials
Company
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed... 
Sector
Pharmaceuticals
Calendar
01/28Earnings Release
More about the company
Ratings of Dr. Reddy's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DR. REDDY'S LABORATORIES LIMITED
06:35aDR REDDY LABORATORIES : Hyderabad, India, January 17th, 2022 - Form 6-K
PU
01/14Asian ADRs Move Higher in Friday Trading
MT
01/12Asian ADRs Move Higher in Wednesday Trading
MT
01/11Asian ADRs Move Sharply Higher in Tuesday Trading
MT
01/10SUB : Intimation - Form 6-K
PU
01/09Investors, Promoters Reportedly Put Curatio Healthcare on the Block
CI
01/07DR REDDY LABORATORIES : Intimation dated January 7, 2022 - Form 6-K
PU
01/07Dr. Reddy's Laboratories Limited Appoints K P Krishnan as Additional Director, Categor..
CI
01/06Asian ADRs Slightly Higher Thursday
MT
01/04Dr Reddy's Laboratories to Launch COVID-19 Treatment Drug Molnupiravir Soon
MT
01/03Asian ADRs Climb Higher in Monday Trading
MT
01/03Indian Indices End in the Green on First Trading Day of 2022; Coal India Jumps 6%
MT
2021Asian ADRs Move Sharply Higher in Thursday Trading
MT
2021Asian ADRs Move Lower in Wednesday Trading
MT
2021Dr. Reddy's Laboratories receives DCGI approval to launch Molnupiravir capsules 200mg (..
AQ
More news
News in other languages on DR. REDDY'S LABORATORIES LIMITED
01/14Les ADR asiatiques en hausse vendredi
01/12Les ADR asiatiques en hausse mercredi
01/11Les ADR asiatiques en forte hausse dans les échanges de mardi
01/09Des investisseurs et des promoteurs auraient mis Curatio Healthcare en vente.
01/07Dr. Reddy's Laboratories Limited nomme K P Krishnan en tant que directeur supplémentair..
More news
Analyst Recommendations on DR. REDDY'S LABORATORIES LIMITED
More recommendations
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | 500124 | INE089A01023 | MarketScreener
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 35
Last Close Price 4 673,60 INR
Average target price 5 449,94 INR
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
Erez Israeli Chief Executive Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Mukesh Rathi Chief Digital & Information Officer
Sector and Competitors
1st jan.Capi. (M$)
DR. REDDY'S LABORATORIES LIMITED-4.79%10 440
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.10%325 363
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
NOVO NORDISK A/S-15.01%223 075